The nurse is caring for a 35-year-old woman taking a beta hydroxy-beta-methylglutaryl coenzyme A(HMG-Co

Choice A rationale

Barrier contraceptives are recommended for women taking HMG-CoA reductase inhibitors due to the potential teratogenic effects of these drugs. This precaution is crucial as these medications can cause fetal harm if used during pregnancy.

Choice B rationale

While ophthalmic examinations may be important for other medications, they are not a primary concern for HMG-CoA reductase inhibitors. These drugs mainly affect cholesterol synthesis and have less direct impact on vision.

Choice C rationale

Although a cholesterol-lowering diet is beneficial, it is not the primary teaching point when discussing HMG-CoA reductase inhibitors. The emphasis should be on medication adherence and managing potential adverse effects.

Choice D rationale

Reporting respiratory symptoms is important for many medications but is not the primary focus for HMG-CoA reductase inhibitors. The priority is to inform patients about the importance of contraception and potential side effects related to the medication.

Choice A rationale

Plaque formation in arteries does not start with platelets and fibrin.

Choice B rationale

Plaque begins with fatty streaks, which are the earliest signs of atherosclerosis and consist of lipid-laden cells in the arterial wall.

Choice C rationale

White blood cells are involved in the inflammatory process of atherosclerosis but do not represent the initial plaque formation.

Choice D rationale

Foam cells, which are lipid-laden macrophages, develop later in the process of plaque formation and contribute to the growth of atherosclerotic lesions. .